4 May 2020 13:58
Horizon Discovery Group plc
Director/PDMR Shareholding
Cambridge, UK, 4 May 2020: Horizon Discovery Group plc (LSE: HZD) ("Horizon", "the Group" or "the Company"), a cell engineering company focused on commercialising the application of gene editing and gene modulation to accelerate scientific innovation and biopharmaceutical drug development, today announces that on 4 May 2020 Susan Searle, a Non-Executive Director of the Company, purchased ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares").
Details of this purchase of Ordinary Shares, and Ms Searle's resulting beneficial interest in the Company's issued share capital, are shown below:
Name of Director | Number of Ordinary Shares purchased | Average Purchase price per share (pence) | Resulting number of Ordinary Shares held | Resulting number of Ordinary Shares held as a percentage of the Company's issued share capital |
Susan Searle* | 20,000 | 102.92p | 74,691 | 0.05% |
*10,000 Ordinary Shares were purchased for her ISA and 10,000 Ordinary Shares for her spouse's ISA.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 | Details of the person discharging managerial responsibilities/person closely associated | ||
a) | Name | Susan Searle | |
2 | Reason for the notification | ||
a) | Position/status | Non-Executive Director | |
b) | Initial notification /Amendment | Initial Notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Horizon Discovery Group plc | |
b) | Legal Entity Identifier | 213800L812B9NI5M3G89 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1.0 pence each GB00BK8FL363 | |
b) | Nature of the transaction | Purchase of shares | |
c) | Currency | GBP | |
d) | Price(s) and volume(s) | Price | No. of shares |
£1.032 | 10,000 | ||
£1.027 | 10,000 | ||
e) | Aggregated information - Aggregated volume - Price - Aggregated total |
20,000 £1.029 £20,584 | |
f) | Date of the transaction | 4 May 2020 | |
g) | Place of the transaction | London Stock Exchange, AIM | |
- ENDS -
For further information from Horizon Discovery Group plc, please contact:
Horizon Discovery Group plc
Terry Pizzie, Chief Executive Officer
Jayesh Pankhania, Chief Financial Officer
Jon Davies, Head of Investor Relations
Tel: +44 (0) 1223 655 580
Numis Securities Limited (Broker and NOMAD)
Freddie Barnfield / Duncan Monteith / Oliver Steele
Tel: +44 (0) 207 260 1000
Consilium Strategic Communications (Financial Media and UK Investor Relations)
Mary-Jane Elliott / Matthew Neal / Melissa Gardiner
Tel: +44 (0) 20 3709 5700
Email: horizon@consilium-comms.com
Westwicke, an ICR Company (US Investor Relations)
Stephanie Carrington
Tel. +1 646-277-1282
Email: horizondiscovery@icrinc.com